載入...
Vitamin K antagonists in children with heart disease: height and VKORC1 genotype are the main determinants of the warfarin dose requirement
Managing vitamin K antagonist (VKA) therapy is challenging in children because of a narrow therapeutic range and wide inter- and intra-individual variability in dose response. Only a few small studies have investigated the effect of nongenetic and genetic factors on the dose response to VKAs in chil...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3384479/ https://ncbi.nlm.nih.gov/pubmed/22130800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-07-365502 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|